York, United Kingdom – January 29, 2008 - Wildwood Ventures Ltd today announced the publication of CurrentPartnering's new report titled Merger and Acquisition Agreements in Biopharma.
CurrentPartnering's Merger and Acquisition Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies.
The report provides a detailed understand and analysis of how and why companies enter merger and acquisition deals. The majority of deals are acquisitions whereby the acquirer acquires the target company in a cash and/or equity transaction.
"This exciting new report fills a significant gap in the business information available to dealmakers in the biopharma sector," stated Steve Poile, CEO of Wildwood Ventures Ltd. "The report provides the reader with the information required to understand and appreciate the trends, structure and detailed terms involved in merger and acquisition deals."
This report also contains over 500 links to online copies of actual merger and acquisition contract documents as submitted to the Securities Exchange Commission by biopharma companies and their partners.
Further information about the reports can be found at: http://reports.currentpartnering.com/reports/deal-type-reports/merger-and-acquisition.html
About Current Partnering:
Current Partnering is the leading publisher of reports focussed on partnering and deal making best practice within the Life Sciences. For more information, visit http://www.currentpartnering.com
About Current Agreements:
Current Agreements is a fully searchable online database providing comprehensive access to deals and alliances data from the Life Sciences. For more information, visit http://www.currentagreements.com